CRH Medical Corporation and WovenX Announce Strategic Partnership to Advance GI Patient Access and Streamline Care Delivery
Collaboration merges clinical and operational expertise with virtual-first innovation to eliminate barriers to GI care.
This collaboration merges CRH’s clinically validated GI solutions with WovenX’s advanced virtual visit platform to create a scalable framework that enhances operational performance, expands patient access, and elevates care delivery across the GI community. WovenX’s on-demand service offering enables practices to increase appointment availability, unlocks underutilized capacity in high-value procedural areas, streamline workflows, and deliver timely, patient-centered care at the speed of need.
“Partnering with
Together, WovenX and CRH are addressing long-standing barriers to access and efficiency, offering providers a cohesive and consumer-centric model for GI care.
“This partnership represents a strategic extension of the solutions we’re already delivering to our GI physician customers, amplifying the value of our collaborative approach,” said
About
WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 42,000 healthcare providers between the US and
About
CRH is a North American company focused on providing gastroenterologists with innovative services and products for the treatment of gastrointestinal diseases. CRH also provides locum tenens and permanent placement anesthesia staffing solutions to provider groups, hospitals, and ASCs. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 50 acquisitions, and now serves over 140 ASCs in 20 states. In addition, CRH owns the “CRH O'Regan System,” a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. Learn more at https://crhmedcorp.com.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610489732/en/
For more information:
Chief Executive Officer
Phone: 404.592.9282
Email: jkreger@crhmedcorp.com
Source: